Draft Guideline for the Prevention of Intravascular Catheter-Related Infections, 56843 [E9-26393]

Download as PDF Federal Register / Vol. 74, No. 211 / Tuesday, November 3, 2009 / Notices document and received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. IV. Paperwork Reduction Act of 1995 This draft guidance contains proposed collections of information that are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520). As required by the PRA, FDA has published an analysis of the information collection concerning the submission of ingredient information (74 FR 45219, September 1, 2009, as corrected by 74 FR 47257, September 15, 2009) and will submit it for OMB approval. Intravascular Device-Related Infections published in 2002. These guidelines provide evidence-based recommendations for preventing intravascular catheter-related infections. DATES: Comments must be received on or before December 3, 2009. ADDRESSES: Comments on the Draft Guideline for the Prevention of Intravascular Catheter-Related Infections should be submitted by email to BSI@cdc.gov or by mail to CDC, Division of Healthcare Quality Promotion, Attn: Resource Center, 1600 Clifton Rd., NE., Mailstop A–31, Atlanta, Georgia 30333; or by fax 404– 639–4049. V. Electronic Access An electronic version of the guidance document is available on the Internet at https://www.regulations.gov and https:// www.fda.gov/TobaccoProducts/ GuidanceComplianceRegulatory Information/default.htm Dated: October 27, 2009. Tanja Popovic, Chief Science Officer, Centers for Disease Control and Prevention. [FR Doc. E9–26393 Filed 11–2–09; 8:45 am] BILLING CODE 4163–18–P Dated: October 29, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–26466 Filed 10–30–09; 11:15 am] National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Draft Guideline for the Prevention of Intravascular Catheter-Related Infections mstockstill on DSKH9S0YB1PROD with NOTICES AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS). ACTION: Notice of availability and request for public comment. SUMMARY: This notice is a request for review of and comment on the Draft Guideline for the Prevention of Intravascular Catheter-Related Infections, available on the following Web site: https://www.cdc.gov/ publiccomments/. This document is for use by infection prevention staff, healthcare epidemiologists, healthcare administrators, nurses, other healthcare providers, and persons responsible for developing, implementing, and evaluating infection prevention and control programs for healthcare settings across the continuum of care. The guideline updates and expands the Guideline for the Prevention of VerDate Nov<24>2008 18:15 Nov 02, 2009 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Career Development & Fellowship Applications. Date: November 4, 2009. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Raul A Saavedra, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS, Nsc; 6001 Executive Blvd., Ste. 3208, Bethesda, MD 20892–9529, 301–496–9223, saavedrr@ninds.nih.gov. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 56843 This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; K01 Conflict Review. Date: November 19, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Joann Mcconnell, PhD, Scientific Review Administrator, Scientific Review Branch, NIH/NINDS/Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, (301) 496–5324, mcconnej@ninds.nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; K99 Special Review. Date: November 20, 2009. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Joann Mcconnell, PhD, Scientific Review Administrator, Scientific Review Branch, NIH/NINDS/Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, (301) 496–5324, mcconnej@ninds.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: October 21, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25923 Filed 11–2–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0523] Product Tracing Systems for Food; Public Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice; request for comment. SUMMARY: The Food and Drug Administration (FDA), in collaboration with the United States Department of Agriculture, Food Safety and Inspection Service (FSIS), is announcing a public meeting regarding product tracing systems for food intended for humans E:\FR\FM\03NON1.SGM 03NON1

Agencies

[Federal Register Volume 74, Number 211 (Tuesday, November 3, 2009)]
[Notices]
[Page 56843]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26393]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Draft Guideline for the Prevention of Intravascular Catheter-
Related Infections

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (DHHS).

ACTION: Notice of availability and request for public comment.

-----------------------------------------------------------------------

SUMMARY: This notice is a request for review of and comment on the 
Draft Guideline for the Prevention of Intravascular Catheter-Related 
Infections, available on the following Web site: https://www.cdc.gov/publiccomments/.
    This document is for use by infection prevention staff, healthcare 
epidemiologists, healthcare administrators, nurses, other healthcare 
providers, and persons responsible for developing, implementing, and 
evaluating infection prevention and control programs for healthcare 
settings across the continuum of care. The guideline updates and 
expands the Guideline for the Prevention of Intravascular Device-
Related Infections published in 2002. These guidelines provide 
evidence-based recommendations for preventing intravascular catheter-
related infections.

DATES: Comments must be received on or before December 3, 2009.

ADDRESSES: Comments on the Draft Guideline for the Prevention of 
Intravascular Catheter-Related Infections should be submitted by e-mail 
to BSI@cdc.gov or by mail to CDC, Division of Healthcare Quality 
Promotion, Attn: Resource Center, 1600 Clifton Rd., NE., Mailstop A-31, 
Atlanta, Georgia 30333; or by fax 404-639-4049.

    Dated: October 27, 2009.
Tanja Popovic,
Chief Science Officer, Centers for Disease Control and Prevention.
[FR Doc. E9-26393 Filed 11-2-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.